Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140


Use of continuous glucose monitoring in young children with type 1 diabetes: implications for behavioral research.

Patton SR, Williams LB, Eder SJ, Crawford MJ, Dolan L, Powers SW.

Pediatr Diabetes. 2011 Feb;12(1):18-24. doi: 10.1111/j.1399-5448.2010.00649.x.


Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.


Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M.

Diabetes Care. 2009 Dec;32(12):2245-50. doi: 10.2337/dc09-0750. Epub 2009 Sep 18.


Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.


A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous glucose monitoring and self-monitoring data.

Patton SR, Midyett LK, Dolan LM, Powers SW.

Diabetes Technol Ther. 2012 Mar;14(3):239-43. doi: 10.1089/dia.2011.0169. Epub 2011 Nov 2.


The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.

Lawson ML, Bradley B, McAssey K, Clarson C, Kirsch SE, Mahmud FH, Curtis JR, Richardson C, Courtney J, Cooper T, Downie CJ, Rajamannar G, Barrowman N; CGM TIME Trial Study Group; JDRF Canadian Clinical Trial Network CCTN1101.

BMC Pediatr. 2014 Jul 18;14:183. doi: 10.1186/1471-2431-14-183.


Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.

Heptulla RA, Allen HF, Gross TM, Reiter EO.

Pediatr Diabetes. 2004 Mar;5(1):10-5.


Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.

Wojciechowski P, Ryś P, Lipowska A, Gawęska M, Małecki MT.

Pol Arch Med Wewn. 2011 Oct;121(10):333-43. Review.


Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.

Hovorka R, Nodale M, Haidar A, Wilinska ME.

Diabetes Technol Ther. 2013 Jan;15(1):4-12. doi: 10.1089/dia.2012.0185. Epub 2012 Oct 9.


A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.

Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group.

Diabetes Care. 2012 Feb;35(2):204-10. doi: 10.2337/dc11-1746. Epub 2011 Dec 30.


Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials.

Szypowska A, Ramotowska A, Dzygalo K, Golicki D.

Eur J Endocrinol. 2012 Apr;166(4):567-74. doi: 10.1530/EJE-11-0642. Epub 2011 Nov 17. Review.


Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Joubert M, Reznik Y.

Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28. Review.


Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV.

Diabetes Care. 2009 Nov;32(11):1947-53. doi: 10.2337/dc09-0889. Epub 2009 Aug 12.


Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S; T1D Exchange Clinic Network.

Diabetes Care. 2014 Oct;37(10):2702-9. doi: 10.2337/dc14-0303. Epub 2014 Jul 10.


Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.

Logtenberg SJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ.

Diabetes Technol Ther. 2009 May;11(5):293-9. doi: 10.1089/dia.2008.0088.


Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.

Kusunoki Y, Katsuno T, Nakae R, Watanabe K, Akagami T, Ochi F, Tokuda M, Murai K, Miuchi M, Miyagawa J, Namba M.

Diabetes Res Clin Pract. 2015 May;108(2):342-9. doi: 10.1016/j.diabres.2015.01.040. Epub 2015 Mar 4.


Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.

Radermecker RP, Fayolle C, Brun JF, Bringer J, Renard E.

Diabetes Metab. 2013 May;39(3):258-62. doi: 10.1016/j.diabet.2012.12.004. Epub 2013 Mar 19.


Continuous glucose monitoring in non-insulin-using individuals with type 2 diabetes: acceptability, feasibility, and teaching opportunities.

Allen NA, Fain JA, Braun B, Chipkin SR.

Diabetes Technol Ther. 2009 Mar;11(3):151-8. doi: 10.1089/dia.2008.0053.

Items per page

Supplemental Content

Write to the Help Desk